CNCR
Loncar Cancer Immunotherapy ETF
1W: +0.0%
1M: -11.3%
3M: -16.4%
1Y: -38.1%
3Y: -36.0%
5Y: -62.0%
$9.02
Last traded 2025-06-03 — delisted
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Portfolio Health Summary
IS Overall Score
38.2
★★★★★
Altman Z-Score
-5.44
Distress
Weight Coverage
97%
of portfolio analyzed
Holdings Matched
29
with fundamental data
InsiderStreet Scorecard
★★★★★
38.2
Top Holdings: Score Breakdown
Risk & Quality Signals
Altman Z-Score
-5.44
Distress Zone (<1.81)
Piotroski F-Score
4.0 / 9
Weak
Beneish M-Score
3.58
Possible Manipulator
Credit Score
—
Earnings Quality
51.6 / 100
Portfolio Valuation
P/E
35.12x
P/B
6.04x
P/S
4.57x
EV/EBITDA
20.11x
EV/Revenue
5.09x
P/FCF
19.43x
P/OCF
16.30x
PEG
10.61x
Earnings Yield
2.85%
FCF Yield
5.15%
OCF Yield
6.14%
Median P/E
-4.14x
Growth & Shareholder Returns
Year-over-Year Growth
Revenue
+10.8%
Net Income
+12.1%
EPS
+21.7%
FCF
+11.8%
EBITDA
+7.5%
Op. Income
—
Compound Growth Rates
Rev CAGR 3Y
+115.2%
Rev CAGR 5Y
+11.6%
EPS CAGR 3Y
+3.3%
EPS CAGR 5Y
+0.0%
FCF CAGR 3Y
-1.4%
FCF CAGR 5Y
+5.7%
EBITDA CAGR 3Y
-13.2%
EBITDA CAGR 5Y
-4.6%
Payout Ratio
53.33%
Buyback Yield
0.55%
Dividend Yield
0.39%
Total Shareholder Return
-6.73%
Earnings Stability
Monte Carlo Price Simulation
Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.
Current Price
$9.02
Median 1Y
$7.37
5th Pctile
$4.16
95th Pctile
$13.08
Ann. Volatility
35.0%
25th–75th percentile
5th–95th percentile
Median path
Historical
All Ratios & Metrics
Valuation (12)
| Metric | Value |
|---|---|
| Portfolio P/E | 35.12 |
| Portfolio P/B | 6.04 |
| Portfolio P/S | 4.57 |
| EV/EBITDA | 20.11 |
| EV/Revenue | 5.09 |
| P/FCF | 19.43 |
| P/OCF | 16.30 |
| PEG | 10.61 |
| Earnings Yield | 2.85% |
| FCF Yield | 5.15% |
| OCF Yield | 6.14% |
| Median P/E | -4.14 |
Profitability & Returns (9)
| Metric | Value |
|---|---|
| Gross Margin | 78.40% |
| Operating Margin | 16.42% |
| Net Margin | 10.04% |
| FCF Margin | 22.00% |
| ROE | 12.43% |
| ROA | 5.16% |
| ROIC | 10.29% |
| ROCE | — |
| Asset Turnover | — |
Leverage & Solvency (6)
| Metric | Value |
|---|---|
| Debt/Equity | 0.90 |
| Debt/Assets | 0.36 |
| Net Debt/EBITDA | 1.83 |
| Interest Coverage | 6.51 |
| Current Ratio | 1.51 |
| Quick Ratio | 1.29 |
Efficiency (4)
| Metric | Value |
|---|---|
| Asset Turnover | — |
| Inventory Turnover | — |
| Receivables Turnover | — |
| Payables Turnover | — |
Growth — YoY (6)
| Metric | Value |
|---|---|
| Revenue Growth | 10.75% |
| Net Income Growth | 12.06% |
| EPS Growth | 21.66% |
| FCF Growth | 11.82% |
| EBITDA Growth | 7.54% |
| Op. Income Growth | — |
Growth — CAGR (16)
| Metric | Value |
|---|---|
| Revenue CAGR 3Y | 115.22% |
| Revenue CAGR 5Y | 11.61% |
| Revenue CAGR 10Y | — |
| EPS CAGR 3Y | 3.31% |
| EPS CAGR 5Y | 0.01% |
| EPS CAGR 10Y | — |
| FCF CAGR 3Y | -1.35% |
| FCF CAGR 5Y | 5.67% |
| FCF CAGR 10Y | — |
| EBITDA CAGR 3Y | -13.25% |
| EBITDA CAGR 5Y | -4.64% |
| EBITDA CAGR 10Y | — |
| Net Income CAGR 3Y | -3.94% |
| Net Income CAGR 5Y | -3.94% |
| Op. Income CAGR 3Y | — |
| Op. Income CAGR 5Y | — |
Quality Scores (13)
| Metric | Value |
|---|---|
| IS Overall | 38.2 |
| IS Profitability | 37.1 |
| IS Balance Sheet | 53.7 |
| IS Earnings Quality | 51.6 |
| IS Growth | 48.7 |
| IS Value | 37.8 |
| IS Momentum | 56.0 |
| IS Safety | 39.3 |
| IS Quality | 50.6 |
| Altman Z-Score | -5.44 |
| Piotroski F-Score | 3.96 |
| Beneish M-Score | 3.58 |
| Credit Score | — |
Dividends & Payout (4)
| Metric | Value |
|---|---|
| Dividend Yield | 0.39% |
| Payout Ratio | 53.33% |
| Buyback Yield | 0.55% |
| Total Shareholder Return | -6.73% |
Growth Stability (4)
| Metric | Value |
|---|---|
| Revenue Stability | 0.608 |
| Earnings Stability | 0.390 |
| Earnings Persistence | 0.671 |
| Margin Stability | 0.356 |
Medians (3)
| Metric | Value |
|---|---|
| Median P/E | -4.14 |
| Median P/B | 3.50 |
| Median Dividend Yield | — |
Coverage Meta (3)
| Metric | Value |
|---|---|
| Weight Coverage % | 96.55% |
| Holdings Matched | 29 |
| Total Holdings | 31 |